How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

194,209 results for

Risk Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. NOACs and Antidepressants ? What are the risks of using these together and how should these risks be managed?

NOACs and Antidepressants ? What are the risks of using these together and how should these risks be managed? NOACs and Antidepressants – What are the risks of using these together and how should these risks be managed? – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice Menu · · Published 20th December 2018, updated 20th December 2018 This article considers the risk of interactions between NOACs and antidepressants. · Non-vitamin K antagonist oral (...) in anticoagulant effect. · See individual drug sections within the main text of this Q&A for NOAC manufacturers’ comments regarding their concomitant use with SJW. · The release of serotonin by platelets is important for maintaining haemostasis. SSRIs and SNRIs inhibit the serotonin transporter responsible for the uptake of serotonin into platelets. Thus SSRIs and SNRIs may increase the risk of bleeding. · Co-administration of NOACs with drugs that affect haemostasis, such as SSRIs or SNRIs, increases the risk

2019 Specialist Pharmacy Services

2. Best practices for managing sleep in intensive care patients to reduce the risk of delirium

Best practices for managing sleep in intensive care patients to reduce the risk of delirium Best practices for managing sleep in intensive care patients to reduce the risk of delirium We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Best practices for managing sleep in intensive care patients to reduce the risk of delirium Share: Reading time approx (...) contribute to the development of delirium. Disturbed sleep is an additional important factor. Question Which practices for sedation in intensive care result in adequate sleep and reduced risk of delirium? The complete Enquiry response is published in Swedish. Click on ”På svenska” in the top menu to read it. SBU Enquiry Service consists of systematic literature searches to highlight studies that can address questions received by the SBU Enquiry Service from Swedish healthcare or social service providers

2018 Swedish Council on Technology Assessement

3. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT)

Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) - Regan - - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term RCOG Scientific Impact Paper Free Access Prenatal Management of Pregnancies (...) detected antibodies in Caucasians are those directed against human platelet antigen (HPA)‐1a (80%) and HPA‐5b (10–15%), which can allow prediction of at‐risk fetuses. Where results are not supportive but clinical suspicion of FNAIT is high, further testing and management should be discussed with the diagnostic laboratory. The prenatal management of FNAIT has undergone a major shift over the past few years. There has been an increase in the use of immunoglobulins following evidence of probable efficacy

2019 Royal College of Obstetricians and Gynaecologists

4. Suicide risk management

Suicide risk management Suicide risk management - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Suicide risk management Last reviewed: February 2019 Last updated: June 2018 Summary Suicide is the thirteenth leading cause of death worldwide, with about 1 million deaths every year due to self-inflicted violence. In people aged 15 to 44 years, self-inflicted injury is the fourth leading cause of death and the sixth (...) leading cause of ill health and disability worldwide, making suicide a significant public health concern. There are 5 components to suicide: ideation, intent, plan, access to lethal means, and history of past suicide attempts. Suicide risk management refers to the identification, assessment, and treatment of a person exhibiting suicidal behaviour (includes death by suicide, suicide attempt, and suicidal ideation). Suicide risk management is an ongoing process in the treatment of a person who has

2018 BMJ Best Practice

5. Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk Management

Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk Management No. 197c-Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk Management - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 4, Pages e353–e358 No. 197c-Maintaining Standards in Antenatal and Intrapartum Fetal Surveillance: Quality Improvement and Risk (...) Management x Robert Liston , MD Vancouver, BC x Diane Sawchuck , RNm PhD Vancouver, BC x David Young , MD Halifax, NS No. 197c (Replaces No. 90 and No. 112), September 2007 (Reaffirmed April 2018) DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Disclaimer: This guideline has been reaffirmed for continued use until further notice. Key Words: , , , , , , , , , , To access this article, please choose from the options below Log In Register

2018 Society of Obstetricians and Gynaecologists of Canada

6. Cyanobacteria and Drinking Water: Occurrence, Risks, Management and Knowledge Gaps for Public Health

Cyanobacteria and Drinking Water: Occurrence, Risks, Management and Knowledge Gaps for Public Health CYANOBACTERIA AND DRINKING WATER: OCCURRENCE, RISKS, MANAGEMENT AND KNOWLEDGE GAPS FOR PUBLIC HEALTH MARCH 2019 Prepared by: Juliette O’Keeffe National Collaborating Centre for Environmental Health Photo credit: Ake via rawpixelNational Collaborating Centre for Environmental Health 1 INTRODUCTION With warming temperatures due to climate change and increased nutrient loads to freshwater systems (...) of importance for public health (PH) professionals and others involved in water management in responding to current and future risks from cyanobacteria in drinking water. This review will outline: Key factors affecting the proliferation of cyanoblooms • The prevalence of cyanoblooms across Canada • The health effects from exposure to cyanotoxins and risks to drinking water supplies • The effectiveness of drinking water treatment for decreasing risks of exposure • Existing approaches to management

2019 National Collaborating Centre for Environmental Health

7. 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy

2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy | Heart Rhythm Society Utility Menu Main navigation Search Main Menu Breadcrumb to access the pocket guide. Ablation Atrial Arrhythmias Clinical Ep Device Therapy Heart Failure / CRT Pediatric Training Ventricular Arrhythmias Downloads Improving the Care

2019 Heart Rhythm Society

8. Management of term infants at increased risk for early onset bacterial sepsis

Management of term infants at increased risk for early onset bacterial sepsis Early-onset neonatal bacterial sepsis (EOS) is sepsis occurring within the first seven days of life. This statement provides updated recommendations for the care of term (≥37 weeks’ gestational age) newborns at risk of EOS, during the first 24 h of life. Maternal group B streptococcal (GBS) colonization in the current pregnancy, GBS bacteruria, a previous infant with invasive GBS disease, prolonged rupture (...) . The management of well-appearing, at-risk term infants depends on the number of risk factors (including maternal GBS colonization) and whether maternal intrapartum antibiotic prophylaxis for GBS was used. In some cases, management should be individualized. Careful assessment and observation of these at-risk infants are a fundamental component of appropriate care. Key Words: Chorioamnionitis; Early-onset sepsis; Group B streptococcus; Newborn

2017 Canadian Paediatric Society

9. Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women

Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women - ACOG Menu ▼ Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous (...) Women Page Navigation ▼ Share: Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women This Practice Advisory has been endorsed by the Society for Maternal-Fetal Medicine. A randomized controlled trial comparing elective induction of labor at 39 weeks gestation with expectant management among low-risk nulliparous women was published in the on August 8, 2018 (1). The study was a large unmasked

2018 American College of Obstetricians and Gynecologists

10. Climate-resilient water safety plans: managing health risks associated with climate variability and change

Climate-resilient water safety plans: managing health risks associated with climate variability and change Climate-resilient water safety plans: managing health risks associated with climate variability and change JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Climate-resilient water safety plans: managing health risks associated with climate variability and change View/ Open (...) Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Climate-resilient water safety plans: managing health risks associated with climate variability and change. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description vi, 82 p. ISBN 9789241512794 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  Assemblée mondiale de la Santé, 51 (‎ A51/40 , 1998 )‎  World Health Assembly, 51 (‎ A51/40 , 1998

2017 WHO

11. Prevention and Management of Cardiovascular Disease Risk in Primary Care

Prevention and Management of Cardiovascular Disease Risk in Primary Care PEER SIMPLIFIED GUIDELINE: PREVENTION AND MANAGEMENT OF CARDIOVASCULAR DISEASE RISK IN PRIMARY CARE Clinical Practice Guideline | February 2015 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. They should be used as an adjunct to sound clinical decision making. OBJECTIVE Alberta primary care (...) clinicians and their teams offer primary and secondary prevention for cardiovascular disease (CVD) focused on CVD risk estimation and lipid management. TARGET POPULATION Men aged 40-75 Women aged 50-75 (optional start at age 40 for simplicity) EXCLUSIONS Men and women of any age with previously diagnosed familial hypercholesterolemia RECOMMENDATIONS ? Screen for CVD risk beginning at age 40 for men and 50 for women. PRACTICE POINT Always use a risk calculator with every lipid measurement to assess CVD

2016 Toward Optimized Practice

12. Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women

Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 36, Issue 9, Supplement 2, Pages S6–S15 Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women DOI: To view the full text, please login as a subscribed user or . Click to view the full (...) As outlined in the following chapters of this update to the Canadian Consensus Conference on Menopause 3 and the Canadian Consensus Conference on Osteoporosis, 4 many of the risk factors for the conditions prevalent among older women are modifiable through changes in lifestyle. To access this article, please choose from the options below Log In Register Purchase access to this article Claim Access If you are a current subscriber with Society Membership or an Account Number, . Subscribe to this title

2014 Society of Obstetricians and Gynaecologists of Canada

13. ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients

ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients SPECIAL ARTICLE ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients M. Hutchings 1 * , M. Ladetto 2 , C. Buske 3 , P. de Nully Brown 1 , A. J. M. Ferreri 4 , M. Pfreundschuh 5† , N. Schmitz 6 , A. Sureda Balari 7 , G. van Imhoff 8 , J. Walewski 9 & the ESMO Lymphoma Consensus Conference Panel Members ‡ 1 Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 2 (...) poorly to therapy and eventually die from their disease. A number of clinical and pathological factors de?ne groups of patients who are at very high risk of such treatment failure. For these ‘ultra-high-risk’ patients, there is no international consensus regarding the opti- mal management approach. In 2015, the European Society for Medical Oncology (ESMO) held a consensus conference on malignant lymphoma in order to develop recommendations on critical subjects that were dif?cult to consider in detail

2018 European Society for Medical Oncology

14. ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients

ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients SPECIAL ARTICLE ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients M. Hutchings 1 * , M. Ladetto 2 , C. Buske 3 , P. de Nully Brown 1 , A. J. M. Ferreri 4 , M. Pfreundschuh 5† , N. Schmitz 6 , A. Sureda Balari 7 , G. van Imhoff 8 , J. Walewski 9 & the ESMO Lymphoma Consensus Conference Panel Members ‡ 1 Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 2 (...) poorly to therapy and eventually die from their disease. A number of clinical and pathological factors de?ne groups of patients who are at very high risk of such treatment failure. For these ‘ultra-high-risk’ patients, there is no international consensus regarding the opti- mal management approach. In 2015, the European Society for Medical Oncology (ESMO) held a consensus conference on malignant lymphoma in order to develop recommendations on critical subjects that were dif?cult to consider in detail

2018 European Society for Medical Oncology

15. CCS guidelines on perioperative cardiac risk assessment and management for patients undergoing noncardiac surgery

CCS guidelines on perioperative cardiac risk assessment and management for patients undergoing noncardiac surgery Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 33, Issue 1, Pages 17–32 Canadian Cardiovascular Society Guidelines on Perioperative Cardiac (...) Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery x Emmanuelle Duceppe Affiliations Department of Medicine, University of Montreal, Montreal, Quebec, Canada Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada , MD a , b , c , x Joel Parlow Affiliations Department of Anesthesiology and Perioperative Medicine

2016 Canadian Cardiovascular Society

16. Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. (PubMed)

Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. With recent changes in UK clinical practice for diabetes care, contemporary estimates of sex disparities in cardiovascular risk and risk factor management are needed.In this retrospective cohort study, using the Clinical Practice Research Datalink linked to hospital and death records for people in England, we identified 79,985 patients with incident T2DM between 2006 (...) -2013 matched to 386,547 patients without diabetes. Sex-stratified Cox models were used to assess cardiovascular risk.Compared to women without T2DM, women with T2DM had a higher cardiovascular event risk (adjusted HR 1.20 [95% CI 1.12-1.28]) with similar corresponding data in men (HR 1.12 [1.06-1.19]) leading to a non-significant higher relative risk in women (risk ratio 1.07 [0.98-1.17]). However, some important sex differences in the management of risk factors were observed. Compared to men

2019 Circulation

17. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department The Ottawa chronic obstructive pulmonary disease (COPD) Risk Scale (OCRS), which consists of 10 criteria, was previously derived to identify patients in the emergency department with COPD who were at high risk for short-term serious outcomes. We sought to validate, prospectively and explicitly, the OCRS when applied by physicians in the emergency (...) department.We conducted this prospective cohort study involving patients in the emergency departments at 6 tertiary care hospitals and enrolled adults with acute exacerbation of COPD from May 2011 to December 2013. Physicians evaluated patients for the OCRS criteria, which were recorded on a data form along with the total risk score. We followed patients for 30 days and the primary outcome, short-term serious outcomes, was defined as any of death, admission to monitored unit, intubation, noninvasive

Full Text available with Trip Pro

2019 EvidenceUpdates

18. Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial

Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial Antisocial behavior and adult criminality often have origins in childhood and are best addressed early in the child's life using evidence-based parenting programs. However, families with additional risk factors do not always make sufficient changes while attending such programs; these families may benefit from additional support.To evaluate the efficacy (...) of adding a 10-session, structured home parent support (HPS) intervention to enhance outcomes for high-risk families attending the Incredible Years Parent (IYP) program.A randomized clinical superiority trial of 126 parents of children aged 3 to 7 years with conduct problems compared the IYP program plus HPS with treatment as usual of the IYP program alone. Child behavior measures were collected before and after treatment and at the 6-month follow-up. Recruitment from 19 IYP groups began February 13

2019 EvidenceUpdates

19. Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide

Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links (...) Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide, Version 1.1 No Thumbnail View/ Open View Statistics Altmetrics Share Citation World Health Organization & Food and Agriculture Organization of the United Nations . (‎2016)‎. Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide, Version

2016 WHO

20. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association Circulation. 2016;134:e535–e578. DOI: 10.1161/CIR.0000000000000450 December 6, 2016 e535 CLINICAL STATEMENTS AND GUIDELINES T he comorbidities of hypertension, diabetes mellitus, obesity, hyperlipidemia, and metabolic syndrome are common in patients with heart failure (HF (...) of overweight and obesity 6 in the general population and in patients with increased cardiovascular risk, and a recent report from the Eighth Joint Na- tional Committee addressed the management of hypertension. 7 However, these guidelines did not specifically address the management of such comorbidities in patients with HF. Similarly, the most recent ACCF/AHA HF practice guidelines 8 in 2013 addressed the overall management of comorbidities in patients with HF in broad terms, but again, specific

Full Text available with Trip Pro

2016 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>